Literature DB >> 3512424

Expression of MHC class II antigens in human B-cell leukaemia, and increased levels of class II antigens and DR-specific mRNA after stimulation with 12-O-tetradecanoyl phorbol-13-acetate.

K Guy, R R Meehan, A E Dewar, D Larhammar.   

Abstract

Cells from the peripheral blood of B-cell chronic lymphocytic leukaemia (CLL) patients were examined serologically for the expression of cell surface MHC class II antigens with monoclonal antibodies (mAbs) specific for the products of HLA-DP, -DQ and -DR genes, and mRNAs from the cells of three patients were analysed with a cDNA probe specific for DR beta chain genes. In 12 cases of CLL studied by indirect immunofluorescence and FACS analysis, a variable proportion of cells failed to express detectable levels of HLA-DP and HLA-DQ antigens at the cell surface, although greater than 90% of the cells had detectable expression of HLA-DR antigens. In all cases, greater than 90% of the cells expressed MHC class I antigens and the majority of cells reacted with the Leu-1 (CD5) mAb. Cells from different patients expressed variable levels of MHC class II antigens, and this was reflected in the finding of variable levels of mRNA detectable with the cDNA probe. Culture of cells with the phorbol ester 12-O-tetradecanoyl phorbol-13-acetate (TPA) induced much increased levels of expression of MHC class II antigens. HLA-DP and -DQ antigens were expressed on greater than 90% of the cells in all cases studied after culture of the cells with TPA, and MHC class II specific mRNA transcripts were correspondingly increased. In a single case of plasma cell leukaemia studied, MHC class II antigens were not detectable at the cell surface and their expression was not induced after culture of the cells with TPA.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3512424      PMCID: PMC1453959     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  31 in total

Review 1.  The human Ia system.

Authors:  R J Winchester; H G Kunkel
Journal:  Adv Immunol       Date:  1979       Impact factor: 3.543

2.  Analysis of cell surfaces by xenogeneic myeloma-hybrid antibodies: differentiation antigens of rat lymphocytes.

Authors:  A F Williams; G Galfrè; C Milstein
Journal:  Cell       Date:  1977-11       Impact factor: 41.582

3.  Differential expression of HLA class II antigens on human fetal and adult lymphocytes and macrophages.

Authors:  J A Edwards; D B Jones; P R Evans; J L Smith
Journal:  Immunology       Date:  1985-07       Impact factor: 7.397

4.  Human Ia molecules carrying DC1 determinants differ in both alpha- and beta-subunits from Ia molecules carrying DR determinants.

Authors:  G Corte; F Calabi; G Damiani; A Bargellesi; R Tosi; R Sorrentino
Journal:  Nature       Date:  1981-07-23       Impact factor: 49.962

5.  The p21 src genes of Harvey and Kirsten sarcoma viruses originate from divergent members of a family of normal vertebrate genes.

Authors:  R W Ellis; D Defeo; T Y Shih; M A Gonda; H A Young; N Tsuchida; D R Lowy; E M Scolnick
Journal:  Nature       Date:  1981-08-06       Impact factor: 49.962

6.  Two populations of Ia-like molecules on a human B cell line.

Authors:  L A Lampson; R Levy
Journal:  J Immunol       Date:  1980-07       Impact factor: 5.422

7.  Expression of HLA-DR by a human monocyte cell line is under transcriptional control.

Authors:  B M Peterlin; T A Gonwa; J D Stobo
Journal:  J Mol Cell Immunol       Date:  1984

8.  Poor mixed lymphocyte reaction stimulatory capacity of leukemic B cells of chronic lymphocytic leukemia patients despite the presence of Ia antigens.

Authors:  J P Halper; S M Fu; A B Gottlieb; R J Winchester; H G Kunkel
Journal:  J Clin Invest       Date:  1979-11       Impact factor: 14.808

9.  Human T cell antigens defined by monoclonal antibodies: the 65,000-dalton antigen of T cells (T65) is also found on chronic lymphocytic leukemia cells bearing surface immunoglobulin.

Authors:  I Royston; J A Majda; S M Baird; B L Meserve; J C Griffiths
Journal:  J Immunol       Date:  1980-08       Impact factor: 5.422

10.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

Authors:  J M Chirgwin; A E Przybyla; R J MacDonald; W J Rutter
Journal:  Biochemistry       Date:  1979-11-27       Impact factor: 3.162

View more
  6 in total

1.  MHC class II antigen and immunoglobulin expression in spontaneous phenotypic variants of the Burkitt's lymphoma cell line Namalwa.

Authors:  K Guy; P G Middleton; L J Docherty; C L De Angelis; C M Steel
Journal:  Immunology       Date:  1986-12       Impact factor: 7.397

2.  T-24.B-cell differentiation factor induces immunoglobulin secretion in human B cells without prior cell replication.

Authors:  G Gallagher; J F Christie; W H Stimson; K Guy; A E Dewar
Journal:  Immunology       Date:  1987-04       Impact factor: 7.397

3.  The primary mediastinal clear cell lymphoma of B-cell type has variable defects in MHC antigen expression.

Authors:  P Möller; B Lämmler; B Herrmann; H F Otto; G Moldenhauer; F Momburg
Journal:  Immunology       Date:  1986-11       Impact factor: 7.397

4.  Differential expression of MHC class II antigens in chronic B-cell disorders.

Authors:  H G Drexler; S M Gignac; M K Brenner; E Coustan-Smith; G Janossy; A V Hoffbrand
Journal:  Clin Exp Immunol       Date:  1988-02       Impact factor: 4.330

5.  Changes of nuclear matrix proteins following the differentiation of human osteosarcoma MG-63 cells.

Authors:  Chun-Hong Zhao; Qi-Fu Li; Yan Zhao; Jing-Wen Niu; Zhi-Xing Li; Jin-An Chen
Journal:  Genomics Proteomics Bioinformatics       Date:  2006-02       Impact factor: 7.691

6.  Lymphocyte activation gene 3: a novel therapeutic target in chronic lymphocytic leukemia.

Authors:  Mika Shapiro; Yair Herishanu; Ben-Zion Katz; Nili Dezorella; Clare Sun; Sigi Kay; Aaron Polliack; Irit Avivi; Adrian Wiestner; Chava Perry
Journal:  Haematologica       Date:  2017-02-02       Impact factor: 9.941

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.